Elevated plasma CXCL12 leads to pain chronicity via positive feedback upregulation of CXCL12/CXCR4 axis in pain synapses

Abstract Background Chronic pain poses a clinical challenge due to its associated costly disability and treatment needs. Determining how pain transitions from acute to chronic is crucial for effective management. Upregulation of the chemokine C-X-C motif ligand 12 (CXCL12) in nociceptive pathway is...

Full description

Bibliographic Details
Published in:	The Journal of Headache and Pain
Main Authors:	Shi-Ze Leng, Mei-Jia Fang, Yi-Min Wang, Zhen-Jia Lin, Qian-Yi Li, Ya-Nan Xu, Chun-Lin Mai, Jun-Ya Wan, Yangyinhui Yu, Ming Wei, Ying Li, Yu-Fan Zheng, Kai-Lang Zhang, Ya-Juan Wang, Li-jun Zhou, Zhi Tan, Hui Zhang
Format:	Article
Language:	English
Published:	BMC 2024-12-01
Subjects:	Pain chronicity Neuropathic pain Plasma CXCL12 Nociceptor plasticity CXCR4
Online Access:	https://doi.org/10.1186/s10194-024-01917-w

Similar Items

The CXCL12/CXCR4 Axis: An Emerging Therapeutic Target for Chronic Pain
by: Chen Z, et al.
Published: (2025-05-01)

Protocatechuic acid as an inhibitor of the JNK/CXCL1/CXCR2 pathway relieves neuropathic pain in CCI rats
by: Hong-xia Chang, et al.
Published: (2022-04-01)

Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
by: Christian Koch, et al.
Published: (2022-12-01)

The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases
by: Rojin Sarallah, et al.
Published: (2025-02-01)

CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
by: Wu Xia, et al.
Published: (2023-08-01)

Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells
by: Heinrich Eileen L, et al.
Published: (2012-04-01)

CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty Arthritis
by: Seong-Kyu Kim, et al.
Published: (2023-02-01)

Association of CXCL12 and CXCR4 Genes Polymorphism with Proliferative Diabetic Retinopathy in Diabetic Patients
by: Saba Gharibi, et al.
Published: (2022-10-01)

Expression of CXCL12-CXCR4/CXCR7 chemokines in splenic fibrosis of cirrhotic spleen and its therapeutic significance
by: Yunfu Lv, et al.
Published: (2023-08-01)

Albiflorin inhibits inflammation to improve liver fibrosis by targeting the CXCL12/CXCR4 axis in mice
by: Lingjie Meng, et al.
Published: (2025-04-01)

CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients
by: Crescenzo D’Alterio, et al.
Published: (2022-10-01)

Blocking of the CXCR4-CXCL12 Interaction Inhibits the Migration of Chicken B Cells Into the Bursa of Fabricius
by: Maria Laparidou, et al.
Published: (2020-01-01)

Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis
by: I. Aversa, et al.
Published: (2017-08-01)

Chemokine CXCL13–CXCR5 signaling in neuroinflammation and pathogenesis of chronic pain and neurological diseases
by: Kaige Zheng, et al.
Published: (2024-10-01)

Expression and regulation of the CXCL9-11 chemokines and CXCR3 receptor in Atlantic salmon (Salmo salar)
by: Natalia Valdés, et al.
Published: (2024-09-01)

Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by: Lingli Wang, et al.
Published: (2025-04-01)

Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases
by: Zijian Pan, et al.
Published: (2022-03-01)

Glia Cells Control Olfactory Neurogenesis by Fine-Tuning CXCL12
by: André Dietz, et al.
Published: (2023-08-01)

Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity
by: Jack Y. Lee, et al.
Published: (2022-06-01)

Correction: Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by: Lingli Wang, et al.
Published: (2025-07-01)

Does the Chemotherapy Protocol Affect CXCL12/CXCR4 Axes in Acute Myeloid Leukemia Patients with Monocytic Differentiation?
by: Bahar Yazdani, et al.
Published: (2022-01-01)

CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
by: Motyka J, et al.
Published: (2023-07-01)

Clinical and prognostic relevance of CXCL12 expression in acute myeloid leukemia
by: Shi-sen Wang, et al.
Published: (2021-07-01)

Involvement of chemokine CXCL12 and its receptor CXCR4 in uterine receptivity and potential relationship to fertility in cattle: a mini review
by: Michael J. D’Occhio, et al.
Published: (2025-08-01)

Extracellular Hsp70 Is Involved in the CXCL12/CXCR4 Pathway in Primary Human Nasal Epithelial Cells: A Preliminary Study
by: Seong Hee Kim, et al.
Published: (2023-11-01)

The effect of CXCL12 on survival outcomes of patients with viral hepatitis-associated hepatocellular carcinoma after hepatectomy
by: Yan Lu, et al.
Published: (2024-05-01)

Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells
by: Jan-Hendrik Bockmann, et al.
Published: (2025-03-01)

Targeting the CXCR4/CXCL12 Axis in Cancer Therapy: Analysis of Recent Advances in the Development of Potential Anticancer Agents
by: Gerardina Smaldone, et al.
Published: (2025-03-01)

SDF-1/CXCL12 and CXCR4 gene variants, and elevated serum SDF-1 levels are associated with preeclampsia
by: Savas Karakus, et al.
Published: (2017-04-01)

The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets
by: Michela Roberto, et al.
Published: (2023-03-01)

Resolvin D2 Reduces Chronic Neuropathic Pain and Bone Cancer Pain via Spinal Inhibition of IL-17 Secretion, CXCL1 Release and Astrocyte Activation in Mice
by: Jun Pang, et al.
Published: (2023-01-01)

CXCL12-CXCR4-Mediated Chemotaxis Supports Accumulation of Mucosal-Associated Invariant T Cells Into the Liver of Patients With PBC
by: Zhilei Chen, et al.
Published: (2021-03-01)

Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy
by: Ruogang Zhao, et al.
Published: (2022-07-01)

The metastatic role of the CXCL10-CXCR3 axis and its therapeutic potential in osteosarcoma
by: Benjamin B. Gyau, et al.
Published: (2025-06-01)

The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context
by: Tzu-Yi Chia, et al.
Published: (2024-01-01)

Multi-omics reveals Dengzhan Shengmai formulation ameliorates cognitive impairments in D-galactose-induced aging mouse model by regulating CXCL12/CXCR4 and gut microbiota
by: Jing-Yi Hou, et al.
Published: (2023-04-01)

LncRNA MALAT1 silencing represses CXCL12-induced proliferation, invasion, and homing behavior in multiple myeloma by inhibiting CXCR4
by: Jing Ning, et al.
Published: (2024-12-01)

Interleukin-1 receptor antagonist inhibits metastatic potential by down-regulating CXCL12/CXCR4 signaling axis in colorectal cancer
by: Jiachi Ma, et al.
Published: (2021-12-01)

The role of CXCL16 in atherosclerosis: from mechanisms to therapy
by: Yue Liu, et al.
Published: (2025-05-01)

Curcumin inhibits ferroptosis-mediated vascular occlusion by regulating the CXCL10/CXCR3 axis in retinopathy of prematurity
by: Rui Niu, et al.
Published: (2025-03-01)